Clinical, imaging and surgical outcomes of secondary intussusceptions in children: a retrospective analysis based on the benign and malignant pathologic lead points.
[BACKGROUND] Timely identification of intussusception secondary to pathological lead points (PLPs) is challenging for surgeons.
- p-value P<0.05
APA
Sun Y, Gong Y, et al. (2025). Clinical, imaging and surgical outcomes of secondary intussusceptions in children: a retrospective analysis based on the benign and malignant pathologic lead points.. Translational pediatrics, 14(11), 2943-2954. https://doi.org/10.21037/tp-2025-533
MLA
Sun Y, et al.. "Clinical, imaging and surgical outcomes of secondary intussusceptions in children: a retrospective analysis based on the benign and malignant pathologic lead points.." Translational pediatrics, vol. 14, no. 11, 2025, pp. 2943-2954.
PMID
41367519
Abstract
[BACKGROUND] Timely identification of intussusception secondary to pathological lead points (PLPs) is challenging for surgeons. This study aimed to comprehensively evaluate the differences between benign and malignant PLPs in a clinical context.
[METHODS] We reviewed 75 patients with secondary intussusception confirmed by surgical pathology between January 2012 and December 2023. Based on their PLPs, patients were categorized into benign and malignant groups, and we compared clinical features, imaging studies, and intraoperative characteristics between the two groups.
[RESULTS] Of the 75 patients, 62 had benign PLPs (most commonly Meckel's diverticulum, 50%) and 13 had malignant PLPs (predominantly lymphoma, 92.3%). Malignant PLPs were associated with a longer duration of illness, higher intussusception frequency, and closer proximity to the ileocecal region (P<0.05). Small bowel-large bowel intussusception was the most common type in both the benign (51.7%) and malignant (61.5%) group, with the most frequent subtype being ileo-ileal (36.7%) in the benign group and ileo-colic (50%) in the malignant group, respectively.
[CONCLUSIONS] In secondary intussusception, malignant PLPs have a longer duration of illness, occur more frequently, and are closer to the ileocecal region. Ultrasound and computed tomography (CT) may complement each other in identifying some PLPs, which is crucial for timely and accurate diagnosis and treatment.
[METHODS] We reviewed 75 patients with secondary intussusception confirmed by surgical pathology between January 2012 and December 2023. Based on their PLPs, patients were categorized into benign and malignant groups, and we compared clinical features, imaging studies, and intraoperative characteristics between the two groups.
[RESULTS] Of the 75 patients, 62 had benign PLPs (most commonly Meckel's diverticulum, 50%) and 13 had malignant PLPs (predominantly lymphoma, 92.3%). Malignant PLPs were associated with a longer duration of illness, higher intussusception frequency, and closer proximity to the ileocecal region (P<0.05). Small bowel-large bowel intussusception was the most common type in both the benign (51.7%) and malignant (61.5%) group, with the most frequent subtype being ileo-ileal (36.7%) in the benign group and ileo-colic (50%) in the malignant group, respectively.
[CONCLUSIONS] In secondary intussusception, malignant PLPs have a longer duration of illness, occur more frequently, and are closer to the ileocecal region. Ultrasound and computed tomography (CT) may complement each other in identifying some PLPs, which is crucial for timely and accurate diagnosis and treatment.
같은 제1저자의 인용 많은 논문 (5)
- Construction of hollow double shell NiMn PBA nanozymes for sensitive sarcosine detection a cascade strategy.
- Polydopamine-modified cyclodextrin metal-organic framework for efficient BCL-2 siRNA delivery in lung cancer therapy.
- Nuclear phosphoinositide signaling in cell biology and disease.
- CircNF1 promotes gastric cancer metastasis by stabilizing HMGA2 mRNA through IGF2BP1 interaction.
- Shaping a pro-carcinogenic hepatic microenvironment by TCDD: An integrated approach combining network toxicology, machine learning, molecular docking, molecular dynamics and experimental validation.